Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b studyLai Wei, Zhongping Duan, Qing Xie et al.|Hepatology International|2018Cited by 22
Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patientsHaiying Lu, Yong Chen, Liwei Zhuang et al.|World Journal of Gastroenterology|2008Cited by 9
Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patientsHaiying Lu, Zheng Zeng, Jun Li et al.|World Journal of Gastroenterology|2007Cited by 8
Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B PatientsJinlin Hou, Jidong Jia, Qin Ning et al.|Journal of Clinical and Translational Hepatology|2024Cited by 7
[Effects of antiviral agents on intrahepatic ccc DNA in HBeAg-positive chronic hepatitis B patients].Haiying Lu, Jun Li, Liwei Zhuang et al.|PubMed|2008Cited by 2